These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 15811916)

  • 1. In vivo aggregation properties of the nuclear poly(A)-binding protein PABPN1.
    Tavanez JP; Calado P; Braga J; Lafarga M; Carmo-Fonseca M
    RNA; 2005 May; 11(5):752-62. PubMed ID: 15811916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic targeting of mutant poly(A)-binding protein nuclear 1 suppresses protein aggregation and toxicity in oculopharyngeal muscular dystrophy.
    Abu-Baker A; Laganiere S; Fan X; Laganiere J; Brais B; Rouleau GA
    Traffic; 2005 Sep; 6(9):766-79. PubMed ID: 16101680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oculopharyngeal muscular dystrophy-like nuclear inclusions are present in normal magnocellular neurosecretory neurons of the hypothalamus.
    Berciano MT; Villagra NT; Ojeda JL; Navascues J; Gomes A; Lafarga M; Carmo-Fonseca M
    Hum Mol Genet; 2004 Apr; 13(8):829-38. PubMed ID: 14976164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble expanded PABPN1 promotes cell death in oculopharyngeal muscular dystrophy.
    Messaed C; Dion PA; Abu-Baker A; Rochefort D; Laganiere J; Brais B; Rouleau GA
    Neurobiol Dis; 2007 Jun; 26(3):546-57. PubMed ID: 17418585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of HSP70 expression and recruitment of HSC70 and HSP70 in the nucleus reduce aggregation of a polyalanine expansion mutant of PABPN1 in HeLa cells.
    Wang Q; Mosser DD; Bag J
    Hum Mol Genet; 2005 Dec; 14(23):3673-84. PubMed ID: 16239242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear polyA-binding protein with a single-domain intracellular antibody.
    Verheesen P; de Kluijver A; van Koningsbruggen S; de Brij M; de Haard HJ; van Ommen GJ; van der Maarel SM; Verrips CT
    Hum Mol Genet; 2006 Jan; 15(1):105-11. PubMed ID: 16319127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dynamism of PABPN1 nuclear inclusions during the cell cycle.
    Marie-Josée Sasseville A; Caron AW; Bourget L; Klein AF; Dicaire MJ; Rouleau GA; Massie B; Langelier Y; Brais B
    Neurobiol Dis; 2006 Sep; 23(3):621-9. PubMed ID: 16860991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy.
    Fan X; Messaed C; Dion P; Laganiere J; Brais B; Karpati G; Rouleau GA
    Can J Neurol Sci; 2003 Aug; 30(3):244-51. PubMed ID: 12945950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of expression and co-localization of heat shock polypeptides with the polyalanine expansion mutant of poly(A)-binding protein N1 after chemical stress.
    Wang Q; Bag J
    Biochem Biophys Res Commun; 2008 May; 370(1):11-5. PubMed ID: 18343218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear compartmentalization and dynamics of the poly(A)-binding protein nuclear 1 (PABPN1) inclusions in supraoptic neurons under physiological and osmotic stress conditions.
    Villagra NT; Bengoechea R; Vaqué JP; Llorca J; Berciano MT; Lafarga M
    Mol Cell Neurosci; 2008 Mar; 37(3):622-33. PubMed ID: 18255312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oculopharyngeal muscular dystrophy: potential therapies for an aggregate-associated disorder.
    Davies JE; Berger Z; Rubinsztein DC
    Int J Biochem Cell Biol; 2006; 38(9):1457-62. PubMed ID: 16530457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PABPN1 polyalanine tract deletion and long expansions modify its aggregation pattern and expression.
    Klein AF; Ebihara M; Alexander C; Dicaire MJ; Sasseville AM; Langelier Y; Rouleau GA; Brais B
    Exp Cell Res; 2008 May; 314(8):1652-66. PubMed ID: 18367172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PABPN1 overexpression leads to upregulation of genes encoding nuclear proteins that are sequestered in oculopharyngeal muscular dystrophy nuclear inclusions.
    Corbeil-Girard LP; Klein AF; Sasseville AM; Lavoie H; Dicaire MJ; Saint-Denis A; Pagé M; Duranceau A; Codère F; Bouchard JP; Karpati G; Rouleau GA; Massie B; Langelier Y; Brais B
    Neurobiol Dis; 2005 Apr; 18(3):551-67. PubMed ID: 15755682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of a Taiwanese family with oculopharyngeal muscular dystrophy.
    Kuo HC; Chen CM; Lee-Chen GJ; Hu FJ; Chu CC; Liou CW; Huang CC
    J Neurol Sci; 2009 Mar; 278(1-2):21-4. PubMed ID: 19101703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of oculopharyngeal muscular dystrophy by muscular expression of Llama single-chain intrabodies in vivo.
    Chartier A; Raz V; Sterrenburg E; Verrips CT; van der Maarel SM; Simonelig M
    Hum Mol Genet; 2009 May; 18(10):1849-59. PubMed ID: 19258344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy.
    Davies JE; Sarkar S; Rubinsztein DC
    Hum Mol Genet; 2006 Jan; 15(1):23-31. PubMed ID: 16311254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for a PABPN1 aggregation-preventing antibody fragment in OPMD.
    Impagliazzo A; Tepper AW; Verrips TC; Ubbink M; van der Maarel SM
    FEBS Lett; 2010 Apr; 584(8):1558-64. PubMed ID: 20226184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice.
    Davies JE; Wang L; Garcia-Oroz L; Cook LJ; Vacher C; O'Donovan DG; Rubinsztein DC
    Nat Med; 2005 Jun; 11(6):672-7. PubMed ID: 15864313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear speckles are involved in nuclear aggregation of PABPN1 and in the pathophysiology of oculopharyngeal muscular dystrophy.
    Bengoechea R; Tapia O; Casafont I; Berciano J; Lafarga M; Berciano MT
    Neurobiol Dis; 2012 Apr; 46(1):118-29. PubMed ID: 22249111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic expression of an expanded (GCG)13 repeat PABPN1 leads to weakness and coordination defects in mice.
    Dion P; Shanmugam V; Gaspar C; Messaed C; Meijer I; Toulouse A; Laganiere J; Roussel J; Rochefort D; Laganiere S; Allen C; Karpati G; Bouchard JP; Brais B; Rouleau GA
    Neurobiol Dis; 2005 Apr; 18(3):528-36. PubMed ID: 15755680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.